A carnosine analog mitigates metabolic disorders of obesity by reducing carbonyl stress

  • 0Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, Fraternal Order of Eagles Diabetes Research Center, University of Iowa, Iowa City, Iowa, USA.

|

|

Summary

This summary is machine-generated.

A new carnosine derivative, carnosinol, effectively scavenges reactive carbonyl species (RCS) linked to obesity. This oral therapy improved metabolic health in rodents without altering body weight, suggesting a novel treatment for metabolic disorders.

Area Of Science

  • Biochemistry
  • Pharmacology
  • Metabolic Diseases

Background

  • Reactive carbonyl species (RCS) are implicated in obesity-related oxidative stress, but their pathogenic role is debated due to broad reactivity and lack of specific therapies.
  • Naturally occurring histidine dipeptides like carnosine have RCS reactivity but are limited by serum carnosinases, hindering therapeutic use.

Purpose Of The Study

  • To design and evaluate carnosinol, a novel, orally bioavailable carnosine derivative resistant to carnosinases, as a targeted scavenger of RCS.
  • To assess carnosinol's efficacy in mitigating metabolic dysfunction and inflammation in rodent models of obesity and metabolic syndrome.

Main Methods

  • Rational design and characterization of carnosinol, a carnosine derivative with enhanced stability and bioavailability.
  • Pharmacological evaluation of carnosinol's potency and selectivity against α,β-unsaturated aldehydes (e.g., 4-hydroxynonenal [HNE]).
  • Assessment of carnosinol's effects on HNE adducts, inflammation, dyslipidemia, insulin resistance, and steatohepatitis in diet-induced obesity rodent models.

Main Results

  • Carnosinol demonstrated high potency and selectivity for α,β-unsaturated aldehydes, with a favorable ADMET profile.
  • Dose-dependent reduction of HNE adducts in liver and skeletal muscle of obese rodents treated with carnosinol.
  • Significant improvements in inflammation, dyslipidemia, insulin resistance, and steatohepatitis, independent of changes in energy expenditure or body weight.

Conclusions

  • Reactive carbonyl species play a pathogenic role in obesity-related metabolic disorders.
  • Carnosinol represents a promising new class of therapeutic compounds for scavenging carbonyl species.
  • Carnosinol's efficacy in preclinical models validates its potential for treating metabolic diseases associated with oxidative stress.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion 01:20

189

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Post-traumatic Stress Disorder 01:27

564

Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...

Obesity 01:24

1.3K

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

What is Metabolism? 00:52

131.9K

Overview

Metabolism represents all of the chemical activity in a cell, including reactions that build molecules (anabolism) and those that break molecules down (catabolism). Anabolic reactions require energy, whereas catabolic reactions provide it. Thus, metabolism describes how cells transform energy through a variety of chemical reactions, which are often made more efficient with the help of enzymes.

Metabolism Is the Sum of All of the Chemical Reactions That Take Place in an Organism

Responses to Heat and Cold Stress 02:45

14.8K

Every organism has an optimum temperature range within which healthy growth and physiological functioning can occur. At the ends of this range, there will be a minimum and maximum temperature that interrupt biological processes.

When the environmental dynamics fall out of the optimal limit for a given species, changes in metabolism and functioning occur – and this is defined as stress. Plants respond to stress by initiating changes in gene expression - leading to adjustments in plant...

Nucleophilic Addition to the Carbonyl Group: General Mechanism 01:18

8.4K

The carbonyl carbon in an aldehyde or ketone is the site of a nucleophilic attack due to its electron-deficient nature. Depending on the strength of the incoming nucleophile, the reaction occurs via different mechanistic pathways.
A stronger nucleophile can directly attack the electrophilic center, the carbonyl carbon. The HOMO orbital of the nucleophile interacts with the LUMO (π* antibonding) orbital present on the carbonyl carbon. This interaction breaks the π bond and shifts the π...